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The glycoprotein P0, the major structural protein of the peripheral nerve myelin, plays a
critical role in holding myelin lamellae together via interaction of both extracellular and
cytoplasmic domains. Mutations in the human P0 gene give rise to severe and progressive
forms of dominantly inherited peripheral neuropathies like CMT1B. Here we report on the
characterization of a bovine P0-derived protein of nearly 26 kD that corresponds to the P0
protein truncated in its cytoplasmic domain. Matrix assisted laser desorption ionization
(MALDI)-time-of-flight/time-of-flight (TOF/TOF) mass spectrometry (MS) analysis on its
tryptic digest has provided a peptide mapping, the main difference of which from the normal
P0 analog was represented by the absence of the cluster of peaks at m/z 1513.7501, 1530.7701,
and 1546.7651. The latter corresponds to the P0 fragment QTPVLYAMLDHSR and to its
pyroglutamic and methionine-oxidized derivatives. The species at 1530.7701 covering the
sequence 186–198 of P0 is not an artifact and might have a functional role in the myelin
architecture. (J Am Soc Mass Spectrom 2006, 17, 117–123) © 2006 American Society for Mass
SpectrometryP0 is a 30 kDa glycoprotein of the peripheral nervemyelin involved in normal myelin organizationand function [1]. The occurrence of some periph-
eral neuropathies, in mice, has been associated to ab-
sence or overexpression of P0 [2]. In addition, mutations
in the human P0 gene cause the inherited demyelinat-
ing peripheral neuropathy Charcot-Marie-Tooth dis-
ease type 1B (CMT1B) [3], the Dejerine-Sottas syndrome
[4] (DSS), and congenital hypomyelination (CH) [5].
It has been recently shown that coexpression of
wild type and cytoplasmically truncated P0 causes
loss of wild-type function, presumably attributable to
a dominant negative effect of the truncated molecule
[6], and it has been demonstrated that the deletion of
a 14 amino acid sequence in the cytoplasmic domain
of P0 abolishes its adhesive function [7].
As a part of our ongoing project on the proteomics
of the peripheral nerves [8 –10], we have isolated by
SDS-PAGE a low-molecular weight P0-related pro-
tein from bovine sciatic nerve. A previous report has
already described the presence of a lower molecular
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from rat. The latter, according to the authors, origi-
nated during the incubation at 37 °C of nerve slice
preparations and of crude myelin incubation by a
cleavage caused by a not well defined protease that
might be present in the myelin [11]. The mass spec-
trometry/mass spectrometry (MS/MS) approach ex-
ploited in the structure elucidation of the proteins
separated by 1-D gel allows overcoming drawbacks
that may arise from protein overlapping in the elec-
trophoretic separation.
Experimental
Protein Extract Preparation
Bovine sciatic nerve, obtained from the local slaugh-
terhouse within one hour of the animal’s slaughter,
was cut into pieces of nearly 1 cm long. These were
snap frozen in liquid nitrogen and immediately trans-
ported to the laboratory and stored frozen at 80 °C
until use. A portion of the frozen nerve (20–30 mg
wet) was thawed and washed in buffer (0.32 M
Sucrose, 20 mM Tris pH 7.5, 1 mM EDTA, 1 M
leupeptin, 1 M aprotinin, 0.2 mM PMSF, 2 mM
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118 QUALTIERI ET AL. J Am Soc Mass Spectrom 2006, 17, 117–123sodium orthovanadate) at 4 °C, rinsed with nondena-
turing lysis buffer (10 mM Tris pH 7.4, 1 mM EDTA,
1 M leupeptin, 1 M aprotinin, 0.2 mM PMSF, 2 mM
Figure 1. Homogeneous 15% SDS-PAGE separation of proteic
extract from bovine sciatic nerve. In the gel, stained with Coomas-
sie blue, the bands indicate the P0, P0-LMW, and P2 proteins. M
molecular weight marker, S  sample.
Figure 2. Peptide mass fingerprint of P0 (a) and
is expanded, in both spectra, by a factor of 6.4 to higsodium-orthovanadate), and directly sonicated by an
Ikasonic U50 sonicator (Ikalabortechnik, Staufen,
Germany) at the highest setting for 3 cycles of 20 s, in
500 l of denaturing lysis buffer (2.5% SDS, 62.5 mM
Tris-HCl pH 6.8, 1 mM EDTA, 0.2 M PMSF, 10%
glycerol, 1 M aprotinin, 1 M leupeptin). The ho-
mogenate was then centrifuged at 13,000 RPM for 10
min in a micro-centrifuge, and the supernatant was
collected. The protein concentration in the extract
was determined by a DC protein kit assay (Bio-Rad
Laboratories, Hercules, CA) using BSA as a standard.
Monodimensional SDS-Polyacrylamide Gel
Electrophoresis (PAGE)
Samples in lysis buffer were loaded onto gel without
boiling and reducing agents (15 g per lane). A
minigel system of Laemmli [12] was utilized, consist-
ing of a 15% homogeneous polyacrylamide resolving
gel. The current was set at 25 mA and the migration
was stopped when the tracking dye reached the
down limit of the gel (nearly two h). The gel was than
subjected to standard Coomassie blue staining.
Protein In-Gel Digestion
The Coomassie blue stained protein bands of interest
were excised from the gel using a razor blade. A
blank control was obtained using a piece of gel cut in
MW (b) tryptic digest. The region above 1460 uP0-L
hlight the P0-LMW missing sequences.
tively
119J Am Soc Mass Spectrom 2006, 17, 117–123 PROTEOMICS OF BOVINE MYELIN SHEATHa blank region of the gel and processed in parallel
with the sample bands. The gel slices were subjected
to reduction by 10 mM DTT and alkylation by 55 mM
iodoacetamide before trypsin digestion [13, 14]. The
gel slices were than washed with 50% acetonitrile/25
mM NH4CO3, dried under vacuum, and rehydrated
in 25 mM NH4CO3 containing trypsin (Promega,
Madison, WI) 0.01 g/l. The mixture was left stand-
ing overnight at 37 °C. Peptide were extracted by one
change of water and two changes of 0.5% TFA/50%
acetonitrile at room-temperature and dried down.
MALDI-TOF TOF MS/MS Peptide Sequence
Mass spectra were recorded on a 4700 Proteomics
analyzer with TOF/TOF optics (Applied Biosystems,
Table 1. MALDI-TOF peptide mapping of spectrum 2A and 2B
Entry Start–End Observed Miss
P0
1 39–55 1951.9700 1
2 46–55 1164.6029 0
3 56–67 1353.6689 0
4 70–78 1107.5699 0
5 70–79 1235.7169 1
6 80–101 2383.0990 0
7 110–120 1314.6920 0
8 186–198 1513.7501 0
9 186–198 1530.7701 0
10 186–198 1546.7651 0
P0 LMW
2= 46–55 1164.6037 0
3= 56–67 1353.6694 0
4= 70–78 1107.5704 0
5= 70–79 1235.7149 1
6= 80–101 2383.1025 0
The mascot score and the sequence coverage were 98 and 39% respecFigure 3. MALDI-TOF/TOF MS/MS spectrFoster City, CA). A 200-Hz frequency-tripled Nd:YAG
laser was used.
An average of 5000 to 8000 laser shots were used to
acquire the MS/MS spectra from -CHCA matrix.
The collisions were carried out using air as collision
gas and by setting the collision energy at 1 KV,
defined as the difference between the accelerating
potential, fixed at 8 kV and the floating cell, kept at 7
kV. The internal calibration was performed by using
five peptides in the range 900–2500 u as standards.
MALDI spectra were elaborated by in-house soft-
ware packages. MASCOT was used for database
search. The search parameters used were peptide
mass tolerance: 50 ppm; enzyme: trypsin (cuts C-term
side of K and R unless next residue is P); variable
modifications: Oxidation (M), Pyro-glu (N-term Q);
r recalibration
Accuracies (ppm) Sequence
1.74 YQPEGGRDAISIFHYAK
2.07 DAISIFHYAK
0.15 GQPYIDEVGTFK
0.09 IQWVGDPHR
42.08 IQWVGDPHRK
4.78 DGSIVIHNLDYGDNGTFTCDVK
1.90 TSQVTLYVFEK
1.85 QTPVLYAMLDHSR Pyro-glu
2.48 QTPVLYAMLDHSR
2.39 QTPVLYAM(O)LDHSR
1.37 DAISIFHYAK
0.22 GQPYIDEVGTFK
0.36 IQWVGDPHR
40.46 IQWVGDPHRK
6.25 DGSIVIHNLDYGDNGTFTCDVK
, for P0., afteum of the tryptic peptide at m/z 1530.77
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tabase: SwissProt 47.8. The detailed analysis of pep-
tide mapping spectra was performed using DE
NOVO sequence software.
Results and Discussion
The one-dimensional gel electrophoresis of the protein
extract of bovine sciatic nerve displayed the known
myelin proteins P0 and P2 as the most abundant bands
(Figure 1). Even though the resolution of this chromato-
graphic separation is not appropriate for an accurate
investigation of the other less abundant nerve proteins,
nevertheless a band migrating faster than that of the P0
one, of 26 kDa molecular weight, was clearly detected
in the Coomassie stained gel.
Mass spectrometry has been used extensively in
neuroscience [15]. The tryptic digests of both P0 and
P0-LMW were submitted to MALDI analysis in a
MALDI-TOF/TOF instrument, and the spectra thus
obtained are displayed in Figure 2a (P0) and 2B (P0-
LMW). The expanded region above 1460 u highlights
the missing sequences in the P0-LMW protein.
The main differences between the two spectra are
attributable to the absence of the clusters centered
around m/z 1530 in the spectrum of Figure 2b. More-
over, the matching of ions sets present in both Figure 2a
and b with the MASCOT database leads to the identi-
fication of both proteins as the well-known P0, with a
similar score. It can be assumed, therefore, that P0 and
P0-LMW proteins are structurally similar. The mass
fingerprint of the spectrum reported in Figure 2a, used
to identify the protein, leads to the recognition of
Scheme 1several sequence-specific peptides (Table 1). Ta 2 3 4 7
121J Am Soc Mass Spectrom 2006, 17, 117–123 PROTEOMICS OF BOVINE MYELIN SHEATHThe protonated species of the modified peptides 8
(m/z 1513.7501), 9 (m/z 1530.7701), and 10 (m/z
1546.7651), respectively (Table 1 and Figure 2a), are
those missing in the spectrum of peptide P0-LMW
(Figure 2b). They are recognized as the peptide QTPV-
LYAMLDHSR, at m/z 1530.7701, its oxidized form, at
m/z 1546.7651 [-M(O)-], and the dehydrated species at
the glutamic moiety at m/z 1513.7501 [pyroGlu-].
The two satellites peptides attributable to classic
chemistry that the wild type sequence has gone through
during sample preparation provide additional clues on
the structure of the 186–198 segment of the P0 protein
sequence, the identification of which was based on the
information input regarding the molecular weight and
of the selected enzymatic procedure only.
Figure 4. MALDI-TOF/TOF MS/MS spectrum
IQWVGDPHRK and (b) IQWVGDKPHR sequen
TOF MS/MS spectrum of the tryptic peptide a
EXPLORER Software.An independent validation of a peptide primarystructure is now offered by the TOF-TOF methodology
that allows the use of the classic ion chemistry princi-
ples to establish the structure of unknowns [16].
e tryptic peptide at m/z 1235.68: Matching of (a)
DATA EXPLORER Software. (c) MALDI-TOF/
1107.57: Matching of IQWVGDPHR by DATA
Table 3. De novo sequences corresponding to the peptide at m/z
1235
Sequences Calculated
Mass Accuracy
(1) (2)
1 IQWVGDKPHR 1235.6649 42.10 0.48
2 IQADVGDKPHR 1235.6496 54.49 11.90
3 IKADVGDKPHR 1235.6860 25.02 17.57
4 IKWVGDKPHR 1235.7013 12.63 29.96of th
ces by
t m/z(1) Initially observed mass m/z 1235.7169; (2) Observed average mass m/z
1235.6643, after three independent calibration in them/z range 11071353.
122 QUALTIERI ET AL. J Am Soc Mass Spectrom 2006, 17, 117–123In particular, an indirect proof of the presence of
Leucine (L) or Isoleucine (I) at the 5 and 9 positions of
the primary structure of the examined peptide (Table 1,
entry 9) would be important [17].
When the protonated peptide at m/z 1530.7701 is
selected by the first TOF and allowed to react in the
floating cell with inert gas (see the Experimental sec-
tion), the MS/MS spectrum reported in Figure 3 was
obtained after ion analysis performed by the second
TOF operated in the reflectron mode. The MS/MS
spectrum provided the complete sequence of the pep-
tide by the appearance of the appropriate y, b, and i ions
(Scheme 1). Moreover, the presence of L residues was
confirmed by the presence of the wi ions at m/z 1046.47
and 568.25.
The QTPVLYAMLDHSR corresponding to the 186–
198 sequence of the bovine P0 myelin was, therefore,
confirmed. Similarly, it was confirmed for the structure
of the modified peptides 8 and 10 (Table 1).
The MS/MS experiments were also carried out on
the other relevant tryptic peptides 2– 4 and 7 (Table 2),
the structures of which were easily confirmed by the
appearance of the full y and b ion series.
A deeper evaluation of the available data were
needed to validate sequence 5 (Table 1). Database
search of the spectrum in Figure 2a identifies this
species, initially observed at m/z 1235.7169, as the seg-
ment 70–79 of P0 myelin with very low mass accuracy,
42.10 ppm. Its MS/MS spectrum (Figure 4a) was
sufficiently informative; however, a relevant fragment
at m/z 409.22 was not recognized.
The de novo-sequencing analysis, starting from m/z
392, provided four other sequences (Table 3), having in
common the last eight amino acid sequences that might
fit the experimental data.
The discriminating parameter among the sequences
1– 4 (Table 3) is represented by the mass accuracy only
(Table 3, third column) that is related to the calibration
initially used in the acquisition of spectrum 2A. The
instrument was then recalibrated three times in the
interval 1107  1353, using the peptides 3 and 4 (Table
1) as internal standards, obtaining an average value of
1235.6643 u and the mass accuracies reported in the
fourth column of Table 3. Peptides 5 (Table 1) and 1
(Table 3) are isobaric, therefore, on the ground of the
recalculated mass accuracy of 0.48 ppm only, both of
them might correspond to the 70–79 segment of P0.
As previously mentioned, the identification of 5 from
mass peptide fingerprint left one mass fragment unas-
signed, whereas the de novo-sequencing analysis of 1
was not able to recognize the species at m/z 1107.68, if
the species were considered to be the 70–79 fragment of
P0 (Figure 4b).
This is a particular case in which the databases or the
fragmentation software cannot unambiguously recog-
nize the structure of a peptide. It can be suggested,
however, that the ionic species at m/z 409.92 could be
due to a consecutive reaction path taken by the ion
fragment at m/z 1107.68. Evidence is provided by theobservation that the MS/MS spectrum of 1107.57 (entry
4, Table 1) gives rise to the fragment at m/z 409.22,
which is in turn recognized either by the database or by
the in silico fragmentation tool as a typical ion of that
sequence (Figure 4c).
It can be assumed, therefore, that the electrophoretic
spot submitted to tryptic digestion corresponds to the
well known P0 protein. Accordingly, the new P0-LMW
myelin protein is of necessity strictly related to it. The
QTPVLYAMLDHSR sequence is, therefore, unambigu-
ously missed in the P0-LMW, and represents a good
marker of the P0 cytoplasmic domain region. The
presence of this truncated protein in samples obtained
from fresh frozen nerve extracts and rigorously pro-
cessed at low temperatures let us to exclude the possible
involvement of an endogenous protease during the
experimental manipulations, as suggested by Agrawal
and coworkers [11]. It can be assumed, therefore, that
this P0 derived protein is not an artifact but that it is
usually present in the myelin membrane and that it
might have a functional role in the myelin architecture.
Conclusions
We have been able to identify by SDS-PAGE and mass
spectrometry a P0-like protein in the pool of myelin
sheath proteins characterized by a molecular weight
lower than that of P0 and lacking almost one peptide
sequence among those already described in previous
experiments [8 –10].
The specificity of tandem mass spectrometry, now
available with MALDI ionization, provides the advan-
tage of validating the peptide structure by means of
classic gas-phase ion-chemistry tools applied to peptide
enzymatic digest, thus offering an unique method to
validate the database searching against mismatch that
could arise from the fact that, in this case too, the
peptide sequence is theoretically reconstructed from
cDNA.
Acknowledgments
The authors acknowledge funds from the University of Calabria
and from MIUR PON avviso 68.
References
1. Quarles, R. H. Myelin sheaths: Glycoproteins involved in their forma-
tion, maintenance, and degeneration. Cell. Mol. Life Sci. 2002, 59,
1851–1871.
2. Wrabetz, L.; Feltri, M. L.; Quattrini, A.; Imperiale, D.; Previtali, S.;
D’Antonio, M.; Martini, R.; Yin, X.; Trapp, B. D.; Zhou, L.; Chiu, S. Y.;
Messing, A. P-0 glycoprotein overexpression causes congenital hypo-
myelination of peripheral nerves. J. Cell. Biol. 2000, 148, 1021–1033.
3. Berger, P.; Young, P.; Suter, U. Molecular cell biology of Charcot-Marie-
Tooth disease. Neurogenetics 2002, 4, 1–15.
4. Warner, L. E.; Hilz, M. J.; Appel, S. H.; Killian, J. M.; Kolodny, E. H.;
Karpati, G.; Carpenter, S.; Watters, G. V.; Wheeler, C.; Witt, D.; Bodell,
A.; Nelis, E.; VanBroeckhoven, C.; Lupski, J. R. Clinical phenotypes of
different MPZ (P-0) mutations may include Charcot-Marie-Tooth type
1B, Dejerine-Sottas, and congenital hypomyelination. Neuron 1996, 17,
451–460.5. Giese, K. P.; Martini, R.; Lemke, G.; Soriano, P.; Schachner, M. Mouse
p(0) gene disruption leads to hypomyelination, abnormal expression of
123J Am Soc Mass Spectrom 2006, 17, 117–123 PROTEOMICS OF BOVINE MYELIN SHEATHrecognition molecules, and degeneration of myelin and axons. Cell 1992,
71, 565–576.
6. Ekici, A. B.; Oezbey, S.; Fuchs, C.; Nelis, E.; Van Broeckhoven, C.;
Schachner, M.; Rautenstrauss, B. Tracing Myelin Protein Zero (P0) in
vivo by construction of P0-GFP fusion proteins. BMC Cell. Biol. 2002, 3,
29–37.
7. Xu, W. B.; Shy, M.; Kamholz, J.; Elferink, L.; Xu, G.; Lilien, J.; Balsamo,
J. Mutations in the cytoplasmic domain of P0 reveal a role for PKC-
mediated phosphorylation in adhesion and myelination. J. Cell. Biol.
2001, 155, 439–445.
8. Le Pera, M.; Urso, E.; Scornaienchi, M. C.; Qualtieri, A. Two dimen-
sional electrophoresis of bovine peripheral nerve: Preliminary data.
Proceedings of the 1st IHUPO National Congress; Napoli, Italy, September,
2003.
9. Sindona, G.; Di Donna, L.; Napoli, A. Identification of the cleavage site
of bovin myelin sheat protein p0 by MALDI-MS/MS. Proceedings of the
1st IHUPO National Congress; Napoli, Italy, September, 2003.
10. Qualtieri, A.; Le Pera, M.; Urso, E.; Crescibene, L.; Valentino, P.;
Bastone, L.; Bagala, A.; Bono. F.; Nistico, R.; Scornaienchi, M. C.;
Quattrone, A. A proteomic approach to the study of the peripheral
neuropathies: Preliminary results. Proceedings of the XXXV Congresso
SIN; Genova, Italy, September 2004. Neurological Sciences 25 (Suppl.),
2004, S66.11. Agrawal, H. C.; Agrawal, D.; Strauss, A. W. Cleavage of the P0
glycoprotein of the rat peripheral nerve myelin: tentative identificationof cleavage site and evidence for the precursor-product relationship.
Neurochem. Res. 1990, 15, 993–1001.
12. Laemmli, U. K. Cleavage of structural proteins during the assembly of the
head of bacteriophage T4. Nature 1970, 227, 680–685.
13. Hellman, U.; Wernstedt, C.; Gonez, J.; Heldin, C. H. Improvement of an
in-gel digestion procedure for the micropreparation of internal protein
fragments for amino-acid sequencing. Anal. Biochem. 1995, 224, 451–455.
14. Jeno, P.; Mini, T.; Moes, S.; Hintermann, E.; Horst. M. Internal sequences
from proteins digested in polyacrylamide gels. Anal. Biochem. 1995, 224,
75–82.
15. Paulson, L.; Persson, R.; Karlsson, G.; Silberring, J.; Bierczynska-
Krzysik, A.; Ekman, R.; Westman-Brinkmalm, A. Proteomics and pep-
tidomics in neuroscience. Experience of capabilities and limitations in a
neurochemical laboratory. J. Mass Spectrom. 2005, 40, 202–213.
16. Aiello, I.; Di Donna, L.; Ghedini, M.; La Deda, M.; Napoli, A.; Sindona,
G. Charge-transfer matrixes as a tool to desorb intact labile molecules by
matrix-assisted laser desorption/ionization. Use of 2,7-dimethoxynaph-
thalene in the ionization of polymetallic porphyrins. Anal. Chem. 2004,
76, 5985–5989.
17. Runker, A. E.; Kobsar, I.; Fink, T.; Loers, G.; Tilling, T.; Putthoff, P.; Wessig,
C.; Martini, R.; Schachner, M. Pathology of a mouse mutation in peripheral
myelin protein P0 is characteristic of a severe and early onset form of
human Charcot-Marie-Tooth type 1B disorder. J. Cell. Biol. 2004, 165,
565–573.
